While several risk factors for a sustained and delayed elevation of IOP in eyes undergoing anti-VEGF injections like the cumulative number of IVIs, intervals between injections and preexisting glaucoma have been described, (23) the etiology of the decrease in peripapillary flux index in frequently treated eyes likely seems multifactorial. The gene discussed is VEGFA; the disease is glaucoma.